ATP7A and cancer: The cuproptosis inhibitory genes, ATP7B and ATP7A, as well as the remaining cuproptosis promoting CuRGs, are highly heterogeneous in tumors but tend to be lowly expressed, which may suggest a lower activation level of cuproptosis in cancer patients.